LIVE WebinarWednesday, November 17, 20213:00 – 4:30 PM Eastern TimeRegister NowIn a growing number of people who contract COVID-19, symptoms persist long after the preliminary SARS-CoV-2 infection subsides. COVID-19 and long COVID clients show a variety of signs that expose SARS-CoV-2s versatility and its long-lasting effect on organ function. While this heterogeneity makes it hard to study the disease, researchers apply every available technology to examine the infection pathological systems. In this webinar brought to you by Cayman Chemical, Floyd Chilton and Thomas Bumol will discuss how they combine metabolomics, transcriptomics, and immune profiling to study SARS-CoV-2s capability to attack numerous organs, even after the virus has been cleared from the body.Topics to be coveredMolecular networks and enzymes that determine COVID-19 mortalityPersistent inflammatory signatures in long COVIDRegister NowMeet the Speakers: Floyd (Ski) H. Chilton, PhDProfessor, School of Nutritional Sciences and WellnessDirector, Precision Nutrition and Wellness InitiativeThe University of ArizonaThomas F. Bumol, PhDExecutive Vice President and DirectorAllen Institute for Immunology
